These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 36912952)

  • 21. Non-invasive Imaging of Localised Scleroderma for Assessment of Skin Blood Flow and Structure.
    Murray AK; Moore TL; Manning JB; Dinsdale G; Wilkinson J; Bhushan M; Griffiths CE; Herrick AL
    Acta Derm Venereol; 2016 Jun; 96(5):641-4. PubMed ID: 26695444
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Morphoea (localised scleroderma) in a patient with mixed connective tissue disease.
    Golding DN
    Ann Rheum Dis; 1986 Jun; 45(6):523-5. PubMed ID: 3729578
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunohistochemical study of perforin and apoptosis stimulation fragment ligand (FasL)in active vitiligo.
    Hassan AS; Kohil MM; Sayed SSE; Mahmoud SB
    Arch Dermatol Res; 2021 Aug; 313(6):453-460. PubMed ID: 32785835
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A comparison of morphoea and lichen sclerosus et atrophicus in vitro: the effects of para-aminobenzoate on skin fibroblasts.
    Griffiths MR; Priestley GC
    Acta Derm Venereol; 1992; 72(1):15-8. PubMed ID: 1350132
    [TBL] [Abstract][Full Text] [Related]  

  • 25. First case series on the use of imiquimod for morphoea.
    Dytoc M; Ting PT; Man J; Sawyer D; Fiorillo L
    Br J Dermatol; 2005 Oct; 153(4):815-20. PubMed ID: 16181467
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Localization of clonal T cells to the epidermis in cutaneous T-cell lymphoma.
    Fivenson DP; Hanson CA; Nickoloff BJ
    J Am Acad Dermatol; 1994 Nov; 31(5 Pt 1):717-23. PubMed ID: 7929915
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Paediatric morphoea: a holistic review. Part 2: diagnosis, measures of disease activity, management and natural history.
    Kaushik A; Mahajan R; De D; Handa S
    Clin Exp Dermatol; 2020 Aug; 45(6):679-684. PubMed ID: 32449205
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The clinical picture of morphea].
    Wojas-Pelc A; Wielowieyska-Szybińska D
    Przegl Lek; 2007; 64(6):438-41. PubMed ID: 18159855
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Abnormal expression of interleukin-6 is associated with epidermal alternations in localized scleroderma.
    Zhu X; Jiang L; Zhong Q; Kong X; Zhang R; Zhu L; Liu Q; Wu W; Tan Y; Wang J; Xia J
    Clin Rheumatol; 2022 Jul; 41(7):2179-2187. PubMed ID: 35277778
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of calcipotriol on lesional fibroblasts from patients with active morphoea.
    Bottomley WW; Jutley J; Wood EJ; Goodfield MD
    Acta Derm Venereol; 1995 Sep; 75(5):364-6. PubMed ID: 8615053
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Morphoea is neither associated with features of Borrelia burgdorferi infection, nor is this agent detectable in lesional skin by polymerase chain reaction.
    Weide B; Schittek B; Klyscz T; Schüz K; Stark M; Rassner G; Wilske B; Garbe C
    Br J Dermatol; 2000 Oct; 143(4):780-5. PubMed ID: 11069456
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Morphoea: a manifestation of infection with Borrelia species?
    Eisendle K; Grabner T; Zelger B
    Br J Dermatol; 2007 Dec; 157(6):1189-98. PubMed ID: 17941947
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunolocalization of tenascin-C in vitiligo.
    Abdou AG; Maraee AH; Shoeib MA; Elbana R
    Appl Immunohistochem Mol Morphol; 2012 Oct; 20(5):501-11. PubMed ID: 22495383
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A case of linear morphoea mistaken for reflex sympathetic dystrophy.
    Thng ST; Wong K
    Singapore Med J; 2013 Mar; 54(3):e50-2. PubMed ID: 23546034
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bullous morphoea: a retrospective study.
    Venturi M; Pinna AL; Pilloni L; Atzori L; Ferreli C; Rongioletti F
    Clin Exp Dermatol; 2017 Jul; 42(5):532-535. PubMed ID: 28543394
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Regulatory T cells in the skin lesions and blood of patients with systemic sclerosis and morphoea.
    Antiga E; Quaglino P; Bellandi S; Volpi W; Del Bianco E; Comessatti A; Osella-Abate S; De Simone C; Marzano A; Bernengo MG; Fabbri P; Caproni M
    Br J Dermatol; 2010 May; 162(5):1056-63. PubMed ID: 20105169
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Children with facial morphoea managing everyday life: a qualitative study.
    Stasiulis E; Gladstone B; Boydell K; O'Brien C; Pope E; Laxer RM
    Br J Dermatol; 2018 Aug; 179(2):353-361. PubMed ID: 29451694
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of CD1a and CD86 on scleroderma Langerhans cells.
    Xie Y; Zhang X; Inoue Y; Wakasugi S; Makino T; Ihn H
    Eur J Dermatol; 2008; 18(1):50-4. PubMed ID: 18086589
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enzymatic dissociation of keratinocytes from human skin biopsies for in vitro cell propagation.
    Hybbinette S; Boström M; Lindberg K
    Exp Dermatol; 1999 Feb; 8(1):30-8. PubMed ID: 10206719
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Localized and systemic scleroderma show different histological responses to methotrexate therapy.
    Seyger MM; van den Hoogen FH; van Vlijmen-Willems IM; van de Kerkhof PC; de Jong EM
    J Pathol; 2001 Apr; 193(4):511-6. PubMed ID: 11276011
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.